-
1
The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in african HIV-infected children.
Published 2014“…Lippincott Williams and Wilkins…”
Journal article -
2
Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis
Published 2016“…Lippincott, Williams & Wilkins…”
Journal article -
3
Virologic response to first-line efavirenz- or nevirapine-based antiretroviral therapy in HIV-infected African children
Published 2017“…Lippincott, Williams & Wilkins…”
Journal article -
4
Virologic response to first-line efavirenz- or nevirapine-based anti-retroviral therapy in HIV-infected African children
Published 2017“…Lippincott, Williams and Wilkins…”
Journal article -
5
Inflammatory biomarkers in HIV-infected children hospitalized for severe malnutrition in Uganda and Zimbabwe
Published 2019“…Lippincott, Williams and Wilkins…”
Journal article -
6
Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy.
Published 2015“…Lippincott, Williams and Wilkins…”
Journal article -
7
Plasma efavirenz exposure, sex, and age predict virological response in HIV-infected African children.
Published 2016“…Lippincott, Williams and Wilkins…”
Journal article -
8
Pubertal development in HIV-infected African children on first-line antiretroviral therapy.
Published 2015“…Lippincott, Williams and Wilkins…”
Journal article